BIOCRYST PHARMACEUTICALS INC
Biological Products, (No Diagnostic Substances) · 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC 27703
官方登记数据
0位关注者
1986成立于
关于 BIOCRYST PHARMACEUTICALS INC
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a commercial stage biotech company that focuses on developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. BioCryst's antiviral drug peramivir (Rapivab) was approved by the FDA in December 2014 and berotralstat (ORLADEYO) was approved in December 2020.
Source: Wikipedia
行业Biological Products, (No Diagnostic Substances)
总部4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC 27703
成立1986
法律形式C Corporation
状态营业中
专利16 项专利
ORAL COMPLEMENT FACTOR D INHIBITORSJP2025179186A · 2025
CRYSTALLINE SALTS OF PLASMA KALLIKREIN INHIBITORJP2024109860A · 2024
关键数据
法律信息
| 法定名称 | BIOCRYST PHARMACEUTICALS INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 882796在 SEC EDGAR 上查看 ↗ |
| EIN | 62-1413174 |
| 行业代码(SIC) | 2836 |
| 注册地址 | 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC 27703 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC 27703
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面